bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.10.21.513182

TGF-β and BMP subfamily pathways in zebrafish spermatogonial niche: A83-01 and DMH1 inhibitor effects in spermatogonial self-renewal and differentiation

Costa, D. F.·Ricci, J. M. B.·Rodrigues, M. S.·Oliveira, M. A.·Doretto, L.·Nobrega, R. H.
View original source ↗Export metadata ↓

Abstract

This study unravels the roles of TGF-{beta} (Transforming growth factor-{beta}) superfamily signaling pathway in the zebrafish spermatogonial activity (self-renewal vs. differentiation) by combining ex vivo and specific pathway inhibitors approaches. The TGF-{beta} superfamily signaling pathway is subdivided into TGF-{beta} and Bone morphogenetic proteins (BMP) subfamilies, and is ubiquitous among metazoans, regulating several biological processes, including spermatogenesis. In this study, we evaluated the function of the TGF-{beta} and BMP subfamily pathways in the zebrafish spermatogonial niche using A83-01 and DMH1 inhibitors, respectively. Our results showed that A83-01 potentiated the follicle-stimulating hormone (Fsh) effects on zebrafish spermatogenesis, reducing type A undifferentiated spermatogonia and increasing differentiated spermatogonia (type Adiff and type B spermatogonia) after 7 days of culture. In agreement with histomorphometrical data, the mRNA levels of dazl (marker of spermatogonial differentiation) and pro-differentiation growth factors, such as igf3 and insl3, were significantly augmented following A83-01. For the BMP signaling pathway, exposure to DMH1 inhibitor showed opposite effects as compared to TGF-{beta} superfamily signaling pathway inhibitor. Histomorphometrical analysis demonstrated an accumulation of type A undifferentiated spermatogonia, while the frequency of differentiated spermatogonia was significantly reduced following co-treatment of DMH1 with Fsh after 7 days of culture. To support this data, expression analysis revealed that BMP signaling pathway inhibitor also decreased the testicular mRNA levels of dazl, igf3 and insl3 when compared to control incubation (Fsh). In conclusion, our study demonstrated that TGF-{beta} and BMP subfamily pathways exert a role in zebrafish spermatogonial niche with antagonistic functions for the spermatogonia fate. The TGF-{beta} subfamily pathway is involved with spermatogonial self-renewal and inhibition of differentiation, whereas the BMP subfamily pathway promotes spermatogonial differentiation. These findings are not only relevant to understanding stem cell biology, but may also be useful in several in vitro assays, promoting control of self-renewal and differentiation by potentially directing these processes.

Explore related subjects

cell biologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Costa, D. F., Ricci, J. M. B., Rodrigues, M. S., Oliveira, M. A., Doretto, L., Nobrega, R. H.. 2022-10-21. TGF-β and BMP subfamily pathways in zebrafish spermatogonial niche: A83-01 and DMH1 inhibitor effects in spermatogonial self-renewal and differentiation. https://doi.org/10.1101/2022.10.21.513182

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗
bioRxiv2026

A LOV-domain photoreceptor mediates phototaxis in brown algae

Phototaxis enables motile cells to navigate light environments and plays a critical role in survival and reproduction across diverse eukaryotic lineages. This ability has evolved independently through distinct photoreceptor systems. Yet, the molecular mechanisms underlying phototaxis remain poorly understood in many major eukaryotic lineages, including stramenopiles. Here, combining functional genetics, cell biology and evolutionary analyses, we identify Helmchrome (HELM), a LOV-domain protein required for phototaxis in the brown alga Ectocarpus. HELM localizes to the posterior flagellum and is responsible for the characteristic flavin-associated fluorescence of brown algal gametes. Loss of HELM abolishes phototactic accumulation and directional orientation without affecting basal motility or fertilization, demonstrating its specific requirement for light-directed movement. Phylogenetic analyses reveal that HELM-like proteins are distributed across diverse stramenopile lineages and that their domain architecture evolved through repeated duplication of an ancestral RGS-LOV module. Our findings identify HELM as a key component of the light-sensing machinery in brown algae, provide a molecular explanation for the long-standing observation of flagellar flavin fluorescence, and reveal a distinct phototaxis system that expands the known diversity of eukaryotic light-sensing mechanisms.

cell biology↗
bioRxiv2026

A distinct chondrogenic progenitor population from human umbilical cord derived mesenchymal stromal cells for osteoarthritis therapy

Stem cell-based cartilage regeneration remains constrained by functional heterogeneity and phenotypic drift in conventional cell sources, compromising durable structural repair. Human umbilical cord-derived mesenchymal stromal cells (UC-MSCs) represent an accessible, off-the-shelf cell source; however, their broad clinical utility is hampered by cellular heterogeneity, leaving the key chondrogenic subpopulation responsible for cartilage repair unresolved. By integrating single-cell transcriptomics with functional assays, we identified and prospectively isolated a distinct, highly expandable subpopulation of skeletal stem cell-like progenitors (U-CPCs) from the human umbilical cord, establishing an extra-skeletal cell source uniquely primed for joint restoration. Single-cell transcriptomics reveal their inherent regulatory landscape, uncovering a distinct transcriptional state uniquely primed for chondrogenesis. In comparison with conventional stem cells and other tissue-derived SSC-like populations (from umbilical cord, bone marrow, adipose tissue, and dental pulp), U-CPCs exhibit a markedly enhanced chondrogenic capacity. In both a mouse cartilage injury model and a rat osteoarthritis model, the administration of U-CPCs effectively mitigates joint degeneration and drives the restoration of a structurally sound, hyaline-like matrix. Mechanistically, U-CPCs secrete extracellular vesicles enriched with microRNA Let-7a-5p, which specifically modulates DUSP7/MAPK/ERK signaling in recipient chondrocytes, thereby restoring extracellular matrix homeostasis and promoting cartilage repair. By characterizing these specialized extra-skeletal progenitors and elucidating both their intrinsic chondrogenic priming and paracrine regulation of host tissue, this study establishes U-CPCs as a robust, lineage-restricted cellular source for osteoarthritis therapy.

cell biology↗